Interaction of Dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system

By Striem S.   Bar-Joseph A.   Berkovitch Y.   Biegon A.  

European Journal of Pharmacology, Vol. 338, Iss. 3, 1997-11 ,pp. : 205-213

Elsevier

Access to resources Recommend Favorite

Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro

By Boireau A.   Malgouris C.   Burgevin M.-C.   Peny C.   Durand G.   Bordier F.   Meunier M.   Miquet J.M.   Daniel M.   Chevet T.   Jimonet P.   Mignani S.   Blanchard J.-C.   Doble A.  

European Journal of Pharmacology, Vol. 300, Iss. 3, 1996-04 ,pp. : 237-246

Elsevier

Access to resources Recommend Favorite

Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action

By  

Current Drug Targets, Vol. 2, Iss. 3, 2001-09 ,pp. : 285-298

Bentham Science Publishers

Access to resources Recommend Favorite

Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo

By Wu H.-Q.   Salituro F.G.   Schwarcz R.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 13-20

Elsevier

Access to resources Recommend Favorite

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia

By Hicks C.A.   Ward M.A.   Swettenham J.B.   O'Neill M.J.  

European Journal of Pharmacology, Vol. 381, Iss. 2, 1999-09 ,pp. : 113-119

Elsevier

Access to resources Recommend Favorite